University of Nebraska

Omaha, Nebraska 68588

11 studies enrolling now · 91 studies all time

What they study most

ADHD, AIDS, Abdominal Aortic Aneurism, Acute Liver Failure, Acute Myeloid Leukemia, Adenocarcinoma, Pancreatic Ductal, Adenovirus, Adenovirus Infection, Adenovirus Infections, Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers, Alzheimer Disease, Amyotrophic Lateral Sclerosis (ALS)

Studies at this site

• A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC — Recruiting now
• Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH — Recruiting now
• Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) — Recruiting now
• A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT — Recruiting now
• Belimumab With Rituximab for Primary Membranous Nephropathy — Recruiting now
• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects — Recruiting now
• MB-105 in Patients With CD5 Positive T-cell Lymphoma — Recruiting now
• Pembrolizumab in Neoplasms or Lymphomas — Paused
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide — Running, not enrolling
• VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease — Running, not enrolling
• Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) — Running, not enrolling
• Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) — Completed
• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) — Running, not enrolling
• A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer — Running, not enrolling
• A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) — Running, not enrolling
• Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells — Enrolling by invitation
• A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) — Running, not enrolling
• Can Intraosseous Antibiotics Improve the Results of Irrigation & Debridement and Prosthetic Retention for PJI? — Enrolling by invitation
• A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Running, not enrolling
• An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma — Completed
• Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors — Stopped early
• A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis — Completed
• REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients — Running, not enrolling
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes — Completed
• PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study — Completed
• Global Utilization And Registry Database for Improved preservAtion of doNor Livers — Enrolling by invitation
• Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma — Completed
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke — Stopped early
• A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain — Completed
• Safety and Efficacy of the SurVeil™ Drug-Coated Balloon — Completed
• Post-market, Prospective Evaluation of PHOTO-oxidized Bovine Pericardium in Vascular Surgery — Completed
• Impella Real-World Surveillance of Patients Using Sodium Bicarbonate — Completed
• The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) — Running, not enrolling
• Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma — Completed
• OCS Lung System EXPAND II Trial — Stopped early
• Determine the Efficacy and Safety of Harvoni in Genotype 1 Chronic Hepatitis c Infected People Who Are Alcoholics — Completed
• Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV — Stopped early
• Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction — Completed
• A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine — Completed
• Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis — Stopped early
• Acquired Methemoglobinemia Observational Registry — Completed
• PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry — Completed
• Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease — NO_LONGER_AVAILABLE
• Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) — Completed
• Utilization of Target Ranges to Treat Parkinson's Disease With the PKG — Stopped early
• T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802) — Stopped early
• Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) — Completed
• Treatment Alternatives in iSGS (NoAAC PR-02 Study) — Completed
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection — Completed